Rejected by WHO, applauded by Bangladesh – why is remdesivir still being used? | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
July 05, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, JULY 05, 2025
Rejected by WHO, applauded by Bangladesh – why is remdesivir still being used?

Covid-19 in Bangladesh

TBS Report
08 April, 2021, 10:30 pm
Last modified: 09 April, 2021, 04:13 pm

Related News

  • Uncertainty in aid commitments threatens Bangladesh's progress in maternal health: UNICEF, UNFPA, WHO
  • 'History will not forgive' failure to seal pandemic deal: WHO chief
  • Japan provides $3.2m to WHO as assistance to ensure quality health services in Cox's Bazar, Bhasan Char
  • Argentina to withdraw from WHO after Trump exit, citing 'deep differences'
  • WHO proposes budget cut after US exit, defends its work

Rejected by WHO, applauded by Bangladesh – why is remdesivir still being used?

There is no problem if doctors use any medicine out of the WHO protocol to save a patient

TBS Report
08 April, 2021, 10:30 pm
Last modified: 09 April, 2021, 04:13 pm
Rejected by WHO, applauded by Bangladesh – why is remdesivir still being used?

Despite the World Health Organization's (WHO) recommendation against the use of the antiviral drug remdesivir for critical Covid-19 patients, Bangladeshi physicians are still administering it.

Doctors say use of remdesivir in the early stages of Covid-19 treatment sometimes shows positive results. They say they are using the locally manufactured drug due to "push selling" of the pharmaceutical companies and "requests by relatives" of patients.

"Many doctors are using remdesivir in a random manner, sometimes even in the absence of any medical emergency," an intensive care unit (ICU) specialist told The Business Standard on condition of anonymity.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Remdesivir started out as an antiviral treatment for Hepatitis C and Ebola and was also tested for SARS and MERS. It was thrust into the spotlight when the Covid-19 pandemic hit the globe, making the drug a household name.

But in November last year, WHO recommended against its use in Covid-19 patients regardless of the severity of the disease. WHO noted that there was no evidence that remdesivir improved the survival of coronavirus patients.

The recommendation was based on WHO's Solidarity Trial on more than 11,000 patients in 30 countries. The WHO panel said data from the trial showed that remdesivir had "no meaningful effect on mortality or on other important outcomes for patients".

"Everyone knows the name of remdesivir due to the media campaign. So, when the condition of a patient deteriorates, relatives ask us to administer the drug," the ICU expert told TBS.

In October last year, remdesivir gained ever more prominence when it was given to then US President Donald Trump as part of his treatment after he had contracted the virus.

In November last year, Jozef Kesecioglu, president of the European Society of Intensive Care Medicine, told Reuters that remdesivir had been classified as a drug one should not use routinely on Covid-19 patients.

Dr Shoman Aniruddha, an anaesthesiologist at the ICU of Mugda General Hospital, told TBS that the hospital had been treating patients according to WHO and health directorate protocols.

"Even then, remdesivir is administered owing to the medical urgency of the patients. Besides, we are getting better results by using drugs that are not in WHO's protocol. Moreover, WHO changes the treatment protocol regularly," said the physician.

Dr Aniruddha said Covid-19 treatment still had no specific medication except oxygen and blood thinners. The antiviral drug could obtain promising results if administered in the early stages when the viral load increased.

Meanwhile, Professor Sayedur Rahman, chairman of the Bangladesh Pharmacological Society, said the WHO protocol was voluntary in nature and countries did not have any obligation to comply with it fully.

Noting that timing is crucial in remdesivir use, he said there is no problem if physicians use any medicine beyond the WHO protocol for the benefit of patients.

In Bangladesh, the price of each vial of remdesivir is Tk5,000-6,000. A patient usually requires five to 10 vials – which means the antiviral medicine costs around Tk60,000 for each patient.

Bangladesh / Top News / Health

remdesivir / Covid -19 in Bangladesh / WHO

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • BNP Standing Committee member Salahuddin Ahmed spoke at a rally organised by the Keraniganj Upazila South BNP today (5 July). Photo: Collected
    AL allies of 16 years now back proportional elections: Salahuddin
  • Labour unrests disrupt CEPZ operations as financial crisis hits factories
    Labour unrests disrupt CEPZ operations as financial crisis hits factories
  • BNP Senior Joint Secretary General Ruhul Kabir Rizvi attended the inauguration of a football tournament at the Dhanmondi Sports Club ground today (5 July). Photo: TBS
    BNP slams Jamaat for trying to 'fish in troubled waters'

MOST VIEWED

  • Ships and shipping containers are pictured at the port of Long Beach in Long Beach, California, US, 30 January 2019. Photo: REUTERS
    Bangladesh expects US tariff relief after Trump announces cuts to Vietnam
  • Customs bureaucracy: Luxury cars rot at Ctg port
    Customs bureaucracy: Luxury cars rot at Ctg port
  • The release was jointly carried out by the Forest Department and the Chattogram Zoo authorities as part of an ongoing initiative to conserve wildlife and maintain ecological balance. Photo: Collected
    33 Python hatchlings born in Ctg zoo released into Hazarikhil sanctuary
  • File photo of a new NBR office in Agargaon, Dhaka. Photo: UNB
    NBR launches 'a-Chalan' for instant online tax payments
  • Officials from various NBR offices in the capital gather at the NBR headquarters in Agargaon, Dhaka on 24 June. File Photo: TBS
    Govt may ease punitive actions against NBR officials
  • Infograph: TBS
    How BB’s floating rate regime calms forex market

Related News

  • Uncertainty in aid commitments threatens Bangladesh's progress in maternal health: UNICEF, UNFPA, WHO
  • 'History will not forgive' failure to seal pandemic deal: WHO chief
  • Japan provides $3.2m to WHO as assistance to ensure quality health services in Cox's Bazar, Bhasan Char
  • Argentina to withdraw from WHO after Trump exit, citing 'deep differences'
  • WHO proposes budget cut after US exit, defends its work

Features

Students of different institutions protest demanding the reinstatement of the 2018 circular cancelling quotas in recruitment in government jobs. Photo: Mehedi Hasan

5 July 2024: Students announce class boycott amid growing protests

23h | Panorama
Contrary to long-held assumptions, Gen Z isn’t politically clueless — they understand both local and global politics well. Photo: TBS

A misreading of Gen Z’s ‘political disconnect’ set the stage for Hasina’s ouster

1d | Panorama
Graphics: TBS

How courier failures are undermining Bangladesh’s online perishables trade

1d | Panorama
The July Uprising saw people from all walks of life find themselves redrawing their relationship with politics. Photo: Mehedi Hasan

Red July: The political awakening of our urban middle class

1d | Panorama

More Videos from TBS

Trump says he is about to raise tariffs as high as 70% on some countries

Trump says he is about to raise tariffs as high as 70% on some countries

1h | TBS World
Will political disputes delay the elections?

Will political disputes delay the elections?

2h | TBS Stories
Initiative to break the deadlock created by the US

Initiative to break the deadlock created by the US

2h | TBS World
Beijing openly sides with Moscow for the first time

Beijing openly sides with Moscow for the first time

5h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net